table of content
1 Introduction to Research & Analysis Reports
1.1 Generic and Biosimilar Pharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic and Biosimilar Pharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Generic and Biosimilar Pharmaceuticals Overall Market Size
2.1 Global Generic and Biosimilar Pharmaceuticals Market Size: 2022 VS 2029
2.2 Global Generic and Biosimilar Pharmaceuticals Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Generic and Biosimilar Pharmaceuticals Players in Global Market
3.2 Top Global Generic and Biosimilar Pharmaceuticals Companies Ranked by Revenue
3.3 Global Generic and Biosimilar Pharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Generic and Biosimilar Pharmaceuticals Companies in Global Market, by Revenue in 2022
3.5 Global Companies Generic and Biosimilar Pharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Generic and Biosimilar Pharmaceuticals Players in Global Market
3.6.1 List of Global Tier 1 Generic and Biosimilar Pharmaceuticals Companies
3.6.2 List of Global Tier 2 and Tier 3 Generic and Biosimilar Pharmaceuticals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Generic and Biosimilar Pharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Erythropoietin
4.1.5 Insulin
4.1.6 Vaccines
4.1.7 Other
4.2 By Type - Global Generic and Biosimilar Pharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Generic and Biosimilar Pharmaceuticals Revenue, 2018-2023
4.2.2 By Type - Global Generic and Biosimilar Pharmaceuticals Revenue, 2024-2029
4.2.3 By Type - Global Generic and Biosimilar Pharmaceuticals Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Generic and Biosimilar Pharmaceuticals Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Other
5.2 By Application - Global Generic and Biosimilar Pharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Generic and Biosimilar Pharmaceuticals Revenue, 2018-2023
5.2.2 By Application - Global Generic and Biosimilar Pharmaceuticals Revenue, 2024-2029
5.2.3 By Application - Global Generic and Biosimilar Pharmaceuticals Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Generic and Biosimilar Pharmaceuticals Market Size, 2022 & 2029
6.2 By Region - Global Generic and Biosimilar Pharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Generic and Biosimilar Pharmaceuticals Revenue, 2018-2023
6.2.2 By Region - Global Generic and Biosimilar Pharmaceuticals Revenue, 2024-2029
6.2.3 By Region - Global Generic and Biosimilar Pharmaceuticals Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Generic and Biosimilar Pharmaceuticals Revenue, 2018-2029
6.3.2 US Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.3.3 Canada Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.3.4 Mexico Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Generic and Biosimilar Pharmaceuticals Revenue, 2018-2029
6.4.2 Germany Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.4.3 France Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.4.4 U.K. Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.4.5 Italy Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.4.6 Russia Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.4.7 Nordic Countries Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.4.8 Benelux Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Generic and Biosimilar Pharmaceuticals Revenue, 2018-2029
6.5.2 China Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.5.3 Japan Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.5.4 South Korea Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.5.5 Southeast Asia Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.5.6 India Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Generic and Biosimilar Pharmaceuticals Revenue, 2018-2029
6.6.2 Brazil Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.6.3 Argentina Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Generic and Biosimilar Pharmaceuticals Revenue, 2018-2029
6.7.2 Turkey Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.7.3 Israel Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.7.4 Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
6.7.5 UAE Generic and Biosimilar Pharmaceuticals Market Size, 2018-2029
7 Generic and Biosimilar Pharmaceuticals Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.1.4 Roche Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.2.4 Amgen Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.3.4 AbbVie Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Company Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.4.4 Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.4.5 Sanofi-Aventis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.5.4 Johnson & Johnson Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.6.4 Pfizer Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.7.4 Novo Nordisk Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.8.4 Eli Lilly Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.9.4 Novartis Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.10.4 Merck Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 3sbio
7.11.1 3sbio Company Summary
7.11.2 3sbio Business Overview
7.11.3 3sbio Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.11.4 3sbio Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.11.5 3sbio Key News & Latest Developments
7.12 Changchun High Tech
7.12.1 Changchun High Tech Company Summary
7.12.2 Changchun High Tech Business Overview
7.12.3 Changchun High Tech Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.12.4 Changchun High Tech Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.12.5 Changchun High Tech Key News & Latest Developments
7.13 CP Guojian
7.13.1 CP Guojian Company Summary
7.13.2 CP Guojian Business Overview
7.13.3 CP Guojian Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.13.4 CP Guojian Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.13.5 CP Guojian Key News & Latest Developments
7.14 Biotech
7.14.1 Biotech Company Summary
7.14.2 Biotech Business Overview
7.14.3 Biotech Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.14.4 Biotech Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.14.5 Biotech Key News & Latest Developments
7.15 Gelgen
7.15.1 Gelgen Company Summary
7.15.2 Gelgen Business Overview
7.15.3 Gelgen Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.15.4 Gelgen Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.15.5 Gelgen Key News & Latest Developments
7.16 Innovent
7.16.1 Innovent Company Summary
7.16.2 Innovent Business Overview
7.16.3 Innovent Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.16.4 Innovent Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.16.5 Innovent Key News & Latest Developments
7.17 Dong Bao
7.17.1 Dong Bao Company Summary
7.17.2 Dong Bao Business Overview
7.17.3 Dong Bao Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.17.4 Dong Bao Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.17.5 Dong Bao Key News & Latest Developments
7.18 Ganlee
7.18.1 Ganlee Company Summary
7.18.2 Ganlee Business Overview
7.18.3 Ganlee Generic and Biosimilar Pharmaceuticals Major Product Offerings
7.18.4 Ganlee Generic and Biosimilar Pharmaceuticals Revenue in Global Market (2018-2023)
7.18.5 Ganlee Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
